Products
IP Reports
Search
Patexia Concierge
Patent Analyzer
Trademark Analyzer
Litigation Analyzer
All Products
Services
Lateral Opportunities
Expert Witness
Research Studies
Strategic Partnership
All Services
IP Community
IP Community
IP Webinars
In the News
Company
About Us
Press Release
Careers
Contact Us
Search
Login
Join
Patexia
Research
Case number
2:21-cv-10403
Lawsuits
Summary
Related Cases
Documents
Discussions
BAUSCH HEALTH IRELAND LIMITED et al v. MYLAN LABORATORIES LTD. et al > Related Cases
Number
Title
Filing date
2:21-cv-10057
BAUSCH HEALTH IRELAND LIMITED et al v. MSN LABORATORIES PRIVATE LTD. et al
Apr 22, 2021
1:21-cv-00611
Bausch Health Ireland Limited et al v. Mylan Laboratories Ltd. et al
Apr 29, 2021
2:21-cv-00573
BAUSCH HEALTH IRELAND LIMITED et al v. MYLAN LABORATORIES LTD et al
Apr 30, 2021
1:22-cv-00020
BAUSCH HEALTH IRELAND LIMITED et al v. MYLAN LABORATORIES LTD. et al
Mar 9, 2022
IPR2022-00722
Mylan Pharmaceuticals Inc. et al. v. Bausch Health Ireland Limited et al.
Mar 21, 2022
IPR2022-01102
Mylan Pharmaceuticals Inc. et al. v. Bausch Health Ireland Limited et al.
Jun 10, 2022
IPR2022-01103
Mylan Pharmaceuticals Inc. et al. v. Bausch Health Ireland Limited et al.
Jun 10, 2022
IPR2022-01104
Mylan Pharmaceuticals Inc. et al. v. Bausch Health Ireland Limited et al.
Jun 10, 2022
IPR2022-01105
Mylan Pharmaceuticals Inc. et al. v. Bausch Health Ireland Limited et al.
Jun 10, 2022
IPR2023-00016
MSN Laboratories Private Ltd. et al. v. Bausch Health Ireland Limited et al.
Oct 12, 2022
2:23-cv-00170
BAUSCH HEALTH IRELAND LIMITED et al v. AUROBINDO PHARMA LIMITED et al
Jan 12, 2023
2nd Annual Patexia Mixer
Our second Mixer will be on January 18th in Santa Monica. Make sure to
Register Today
Menu
Log In
Products
IP Reports
Search
Patexia Concierge
Patent Analyzer
Trademark Analyzer
Litigation Analyzer
All Products
Services
Lateral Opportunities
Expert Witness
Research Studies
Strategic Partnership
All Services
IP Community
IP Community
IP Webinars
In the News
Company
About Us
Press Release
Careers
Contact Us